CEFQNOR 2.5

CEFQNOR 2.5

Cefquinome 2.5% Injection

Composition

Each ml contains:

• Cefquinome (as sulfate) ............... 25 mg

• Excipients ........................................ q.s. to 1 ml

Pharmaceutical Form

Sterile injectable suspension/solution (as formulated).

Therapeutic Class

Fourth-generation cephalosporin antibiotic.

Indications

CEFQNOR 2.5 is indicated for the treatment of severe bacterial infections caused by Gram-positive and Gram-negative bacteria susceptible to Cefquinome, including:

• Respiratory tract infections

• Mastitis

• Septicemia

• Skin and soft tissue infections

• Metritis and uterine infections

Target Species

• Cattle

• Sheep

• Goats

• Camels

Mechanism of Action

Cefquinome inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), resulting in rapid bactericidal activity.
As a 4th generation cephalosporin, it shows high stability against β-lactamases.

Dosage & Administration

Cattle, Sheep, Goats & Camels:

• 1 mg Cefquinome/kg body weight

• (Equivalent to 1 ml per 25 kg body weight)

Route of Administration:

• Intramuscular (IM)

• Subcutaneous (SC) (where appropriate)

Treatment duration: 3–5 days, or as directed by the veterinarian.

Contraindications

• Hypersensitivity to cephalosporins or β-lactam antibiotics

• Do not use in animals with known severe allergic reactions to penicillins

Side Effects

• Mild local reactions at injection site

• Rare hypersensitivity reactions

Withdrawal Period (indicative – subject to local regulations)

• Meat:

  • Cattle: 8–10 days

  • Sheep & Goats: 6–8 days

• Milk:

  • According to local regulatory approval

Storage Conditions

• Store below 25°C

• Protect from light

• Do not freeze

Presentation

• 50 ml

• 100 ml multidose vials